Browse EV MemProt Atlas
- Frequency:
- literature support frequency.
- EVMP score:
annotation confidence score.
Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| LPAR6 | P43657 | Lysophosphatidic acid receptor 6 (LPA receptor 6) (LPA-6) (Oleoyl-L-alpha-lysophosphatidic acid receptor) (P2Y purinoceptor 5) (P2Y5) (Purinergic receptor 5) (RB intron encoded G-protein coupled receptor) | Disease related genesG-protein coupled receptorsHuman disease related genesPotential drug targetsPredicted membrane proteins | 7 | Receptor-signaling mediation | 2 | 0.50 | |||
| LRFN2 | Q9ULH4 | Leucine-rich repeat and fibronectin type-III domain-containing protein 2 (Synaptic adhesion-like molecule 1) | Predicted membrane proteins | 1 | Other mediation | 2 | 0.50 | |||
| LRP12 | Q9Y561 | Low-density lipoprotein receptor-related protein 12 (LDLR-related protein 12) (LRP-12) (Suppressor of tumorigenicity 7 protein) | Disease related genesHuman disease related genesPredicted membrane proteins | 1 | Metabolism mediation | 2 | 0.50 | |||
| LX15B | O15296 | Polyunsaturated fatty acid lipoxygenase ALOX15B (15-lipoxygenase 2) (15-LOX-2) (Arachidonate 15-lipoxygenase B) (15-LOX-B) (EC 1.13.11.33) (Arachidonate 15-lipoxygenase type II) (Linoleate 13-lipoxygenase 15-LOb) (EC 1.13.11.-) | EnzymesMetabolic proteinsPredicted intracellular proteins | Adhesion and uptake mediationFusion and delivery mediationMetabolism mediation | 2 | 0.50 | ||||
| M3K12 | Q12852 | Mitogen-activated protein kinase kinase kinase 12 (EC 2.7.11.25) (Dual leucine zipper bearing kinase) (DLK) (Leucine-zipper protein kinase) (ZPK) (MAPK-upstream kinase) (MUK) (Mixed lineage kinase) | EnzymesPredicted intracellular proteinsTransporters | Receptor-signaling mediation | 2 | 0.50 | ||||
| M4A12 | Q9NXJ0 | Membrane-spanning 4-domains subfamily A member 12 | Predicted membrane proteins | 4 | Other mediation | 2 | 0.50 | |||
| MADD | Q8WXG6 | MAP kinase-activating death domain protein (Differentially expressed in normal and neoplastic cells) (Insulinoma glucagonoma clone 20) (Rab3 GDP/GTP exchange factor) (RabGEF) (Rab3 GDP/GTP exchange protein) (Rab3GEP) | Disease related genesHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins | Fusion and delivery mediationReceptor-signaling mediation | 2 | 0.50 | ||||
| MEG10 | Q96KG7 | Multiple epidermal growth factor-like domains protein 10 (Multiple EGF-like domains protein 10) | 1 | Adhesion and uptake mediationImmune mediation | 2 | 0.50 | ||||
| MLIP | Q5VWP3 | Muscular LMNA-interacting protein (Cardiac Isl1-interacting protein) (CIP) (Muscular-enriched A-type laminin-interacting protein) | Disease related genesPredicted intracellular proteins | Other mediation | 2 | 0.50 | ||||
| MLKL | Q8NB16 | Mixed lineage kinase domain-like protein (hMLKL) | Clinical-translation mediationFusion and delivery mediation | 2 | 0.50 | |||||
| MMP28 | Q9H239 | Matrix metalloproteinase-28 (MMP-28) (EC 3.4.24.-) (Epilysin) | EnzymesPredicted secreted proteins | Fusion and delivery mediationImmune mediation | 2 | 0.50 | ||||
| MOES | P26038 | Moesin (Membrane-organizing extension spike protein) | Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.50 | ||||
| MYO10 | Q9HD67 | Unconventional myosin-X (Unconventional myosin-10) | Plasma proteinsPredicted intracellular proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediation | 2 | 0.50 | ||||
| MYOF | Q9NZM1 | Myoferlin (Fer-1-like protein 3) | Disease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters | 1 | Fusion and delivery mediation | 2 | 0.50 | |||
| NF1 | P21359 | Neurofibromin (Neurofibromatosis-related protein NF-1) [Cleaved into: Neurofibromin truncated] | Cancer-related genesDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsRAS pathway related proteins | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation | 2 | 0.50 | ||||
| NFAM1 | Q8NET5 | NFAT activation molecule 1 (Calcineurin/NFAT-activating ITAM-containing protein) (NFAT-activating protein with ITAM motif 1) | Predicted membrane proteins | 1 | Fusion and delivery mediationImmune mediationReceptor-signaling mediation | 2 | 0.50 | |||
| NGEF | Q8N5V2 | Ephexin-1 (Eph-interacting exchange protein) (Neuronal guanine nucleotide exchange factor) | Predicted intracellular proteins | Receptor-signaling mediation | 2 | 0.50 | ||||
| NID2 | Q14112 | Nidogen-2 (NID-2) (Osteonidogen) | Plasma proteinsPredicted intracellular proteinsPredicted secreted proteins | Adhesion and uptake mediation | 2 | 0.50 | ||||
| NLS1 | Q8NA29 | Sodium-dependent lysophosphatidylcholine symporter 1 (NLS1) (Sodium-dependent LPC symporter 1) (Major facilitator superfamily domain-containing protein 2A) (HsMFSD2A) (MFSD2a) | Disease related genesHuman disease related genesPotential drug targetsPredicted membrane proteinsTransporters | 12 | Fusion and delivery mediationMetabolism mediation | 2 | 0.50 | |||
| O10P1 | Q8NGE3 | Olfactory receptor 10P1 (Olfactory receptor 10P2) (Olfactory receptor 10P3) (Olfactory receptor OR12-7) | 7 | Other mediation | 2 | 0.50 | ||||
| OPRK | P41145 | Kappa-type opioid receptor (K-OR-1) (KOR-1) | FDA approved drug targetsG-protein coupled receptorsPredicted membrane proteinsTransporters | 7 | Bipolar disorderChronic painCoronary vasospastic diseaseDepressionIndeterminate colitisIrritable bowel syndromeNeurodegenerative disorderNon-specific cutaneous vascular symptonObesityOpioid use disorderPainPrurigoPruritusSubstance abuseUnspecific substance use disorder | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 2 | 0.50 | ||
| OSCAR | Q8IYS5 | Osteoclast-associated immunoglobulin-like receptor (Osteoclast-associated receptor) (hOSCAR) (Polymeric immunoglobulin receptor 3) (PIgR-3) (PIgR3) (Poly-Ig receptor 3) | Immune mediationReceptor-signaling mediation | 2 | 0.50 | |||||
| PANX1 | Q96RD7 | Pannexin-1 (PANX1) [Cleaved into: Caspase-activated pannexin-1 (Caspase-activated PANX1)] | Disease related genesHuman disease related genesPotential drug targetsPredicted membrane proteinsTransporters | 4 | Fusion and delivery mediationImmune mediation | 2 | 0.50 | |||
| PAR2 | P55085 | Proteinase-activated receptor 2 (PAR-2) (Coagulation factor II receptor-like 1) (G-protein coupled receptor 11) (Thrombin receptor-like 1) [Cleaved into: Proteinase-activated receptor 2, alternate cleaved 1; Proteinase-activated receptor 2, alternate cleaved 2] | G-protein coupled receptorsPredicted membrane proteinsTransporters | 7 | Clinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation | 2 | 0.50 | |||
| PARD3 | Q8TEW0 | Partitioning defective 3 homolog (PAR-3) (PARD-3) (Atypical PKC isotype-specific-interacting protein) (ASIP) (CTCL tumor antigen se2-5) (PAR3-alpha) | Disease related genesPlasma proteinsPredicted intracellular proteins | Clinical-translation mediationFusion and delivery mediationReceptor-signaling mediation | 2 | 0.50 |